To establish such criteria for defining “acute liver failure” in Japan, two types of nationwide surveys were performed [30]; a survey of the commercial kits used for the measurement of prothrombin time at institutions to which hepatology specialists were affiliated, and a survey of acute liver failure patients who were excluded from the disease entities of fulminant hepatitis and LOHF. The gene discussed is F2; the disease is acute liver failure.